{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:18:26Z","timestamp":1790111906099,"version":"4.0.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,7,23]],"date-time":"2008-07-23T00:00:00Z","timestamp":1216771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2008,7,23]],"date-time":"2008-07-23T00:00:00Z","timestamp":1216771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Glycoconj J"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1007\/s10719-008-9160-6","type":"journal-article","created":{"date-parts":[[2008,7,22]],"date-time":"2008-07-22T07:13:26Z","timestamp":1216710806000},"page":"41-55","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Investigation towards bivalent chemically defined glycoconjugate immunogens prepared from acid-detoxified lipopolysaccharide of Vibrio cholerae O1, serotype Inaba"],"prefix":"10.1007","volume":"26","author":[{"given":"Cyrille","family":"Grandjean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Boutonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Dassy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence A.","family":"Mulard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,7,23]]},"reference":[{"key":"9160_CR1","first-page":"10","volume-title":"Cholera vaccines: a new public health tool?","author":"WHO Meeting","year":"2002","unstructured":"WHO Meeting: Cholera vaccines: a new public health tool?, pp. 10\u201311. Geneva, Switzerland (2002), December"},{"key":"9160_CR2","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1586\/14760584.5.4.483","volume":"5","author":"E.T. Ryan","year":"2006","unstructured":"Ryan, E.T., Calderwood, S.B., Qadri, F.: Live attenuated oral cholera vaccines. Expert Rev. Vaccines 5, 483\u2013494 (2006). doi:10.1586\/14760584.5.4.483","journal-title":"Expert Rev. Vaccines"},{"key":"9160_CR3","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S1473-3099(07)70138-X","volume":"7","author":"J.N. Zuckerman","year":"2007","unstructured":"Zuckerman, J.N., Rombo, L., Fish, A.: The true burden and risk of cholera: implications for prevention and control. Lancet Infect. Dis. 7, 521\u2013530 (2007). doi:10.1016\/S1473-3099(07)70138-X","journal-title":"Lancet Infect. Dis."},{"key":"9160_CR4","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/978-1-59745-370-7","volume":"25","author":"C.L. Chaignat","year":"2007","unstructured":"Chaignat, C.L., Monti, V.: Use of oral cholera vaccine in complex emergencies: what next? Summary report of an expert meeting and recommendations of WHO. J. Health Popul. Nutr. 25, 244\u2013261 (2007)","journal-title":"J. Health Popul. Nutr."},{"key":"9160_CR5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/01.revmedmi.0000174307.33651.81","volume":"16","author":"S. Kabir","year":"2005","unstructured":"Kabir, S.: Cholera vaccines: the current status and problems. Rev. Med. Microb. 16, 101\u2013116 (2005)","journal-title":"Rev. Med. Microb."},{"key":"9160_CR6","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1348-0421.2006.tb03866.x","volume":"50","author":"D. Provenzano","year":"2006","unstructured":"Provenzano, D., Kovac, P., Wade, W.F.: The ABCs (antibody, B cells, and carbohydrate epitopes) of cholera immunity: considerations for an improved vaccine. Microbiol. Immunol. 50, 899\u2013207 (2006)","journal-title":"Microbiol. Immunol."},{"key":"9160_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0140-6736(03)15328-7","volume":"363","author":"D.A. Sack","year":"2004","unstructured":"Sack, D.A., Sack, R.B., Nair, G.B., Siddique, A.K.: Cholera. Lancet 363, 223\u2013233 (2004). doi:10.1016\/S0140-6736(03)15328-7","journal-title":"Lancet"},{"key":"9160_CR8","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S0764-4469(00)87188-7","volume":"322","author":"A.A. Lindberg","year":"1999","unstructured":"Lindberg, A.A.: Polyosides (encapsulated bacteria). C. R. Acad. Sci. III 322, 925\u2013932 (1999). doi:10.1016\/S0764-4469(00)87188-7","journal-title":"C. R. Acad. Sci. III"},{"key":"9160_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1365-2249.2000.01109.x","volume":"119","author":"D. Goldblatt","year":"2000","unstructured":"Goldblatt, D.: Conjugate vaccines. Clin. Exp. Immunol. 119, 1\u20133 (2000). doi:10.1046\/j.1365-2249.2000.01109.x","journal-title":"Clin. Exp. Immunol."},{"key":"9160_CR10","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/infdis\/120.2.192","volume":"120","author":"W.M. McCormack","year":"1969","unstructured":"McCormack, W.M., Chakraborty, J., Rahman, A.S., Mosley, W.H.: Vibriocidal antibody in clinical cholera. J. Infect. Dis. 120, 192\u2013201 (1969)","journal-title":"J. Infect. Dis."},{"key":"9160_CR11","first-page":"803","volume-title":"New generation of Vaccines","author":"J.B. Robbins","year":"1997","unstructured":"Robbins, J.B., Schneerson, R., Szu, S.C.: Chapter 52: O-Specific polysaccharide\u2013protein conjugates for prevention of enteric bacterial diseases. In: Levine, M.M., Woodrow, G.G., Kapper, J.B., Cobon, G.S. (eds.) New generation of Vaccines, pp. 803\u2013815, 2nd edn. Marcel Dekker, New York (1997)","edition":"2"},{"key":"9160_CR12","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1128\/cdli.2.6.685-688.1995","volume":"2","author":"F. Qadri","year":"1995","unstructured":"Qadri, F., Mohi, G., Hossain, J., Azimi, T., Khan, A.M., Salam, M.A., Sack, R.B., Albert, M.J., Svennerholm, A.M.: Comparison of vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1. Clin. Diagn. Lab. Immunol. 2, 685\u2013688 (1995)","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"9160_CR13","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1128\/iai.65.9.3571-3576.1997","volume":"65","author":"F. Qadri","year":"1997","unstructured":"Qadri, F., Wenneras, C., Albert, M.J., Hossain, J., Mannoor, K., Begum, Y.A., et al.: Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1. Infect. Immun. 65, 3571\u20133576 (1997)","journal-title":"Infect. Immun."},{"key":"9160_CR14","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1128\/IAI.69.5.3488-3493.2001","volume":"69","author":"A. Boutonnier","year":"2001","unstructured":"Boutonnier, A., Villeneuve, S., Nato, F., Dassy, B., Fournier, J.-M.: Preparation, immunogenicity, and protective efficacy, in a murine model, of a conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of Vibrio cholerae O139 bound to tetanus toxoid. Infect. Immun. 69, 3488\u20133493 (2001). doi:10.1128\/IAI.69.5.3488-3493.2001","journal-title":"Infect. Immun."},{"key":"9160_CR15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0020-2452(96)85763-0","volume":"93","author":"J.A. Johnson","year":"1995","unstructured":"Johnson, J.A., Joseph, A., Morris Jr., J.G.: Capsular polysaccharide\u2013protein conjugate vaccines against Vibrio cholerae O139 Bengal. Bull. Inst. Pasteur 93, 285\u2013290 (1995). doi:10.1016\/0020-2452(96)85763-0","journal-title":"Bull. Inst. Pasteur"},{"key":"9160_CR16","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.1128\/IAI.68.9.5037-5043.2000","volume":"68","author":"S. Kossaczka","year":"2000","unstructured":"Kossaczka, S., Shiloach, J., Johnson, V., Taylor, D.N., Finkelstein, R.A., Robbins, J.B., et al.: Vibrio cholerae O139 conjugate vaccines: synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diphteria toxin mutant in mice. Infect. Immun. 68, 5037\u20135043 (2000). doi:10.1128\/IAI.68.9.5037-5043.2000","journal-title":"Infect. Immun."},{"key":"9160_CR17","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1023\/A:1007164216202","volume":"17","author":"S. Kossaczka","year":"2000","unstructured":"Kossaczka, S., Szu, S.C.: Effect of synthetic schemes to prepare immunogenic conjugates of Vibrio cholerae O139 capsular polysaccharide with chicken serum albumin. Glycoconj. J. 17, 425\u2013433 (2000). doi:10.1023\/A:1007164216202","journal-title":"Glycoconj. J."},{"key":"9160_CR18","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1086\/339583","volume":"185","author":"A. Chernyak","year":"2002","unstructured":"Chernyak, A., Kondo, S., Wade, T.K., Meeks, M.D., Alzari, P.M., Fournier, J.-M., et al.: Induction of protective immunity by synthetic Vibrio cholerae hexasaccharide derived from V. cholerae O1 Ogawa lipolysaccharide bound to a protein carrier. J. Infect. Dis. 185, 950\u2013962 (2002). doi:10.1086\/339583","journal-title":"J. Infect. Dis."},{"key":"9160_CR19","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1016\/j.carres.2005.07.017","volume":"340","author":"R. Saksena","year":"2005","unstructured":"Saksena, R., Ma, X., Wade, T.K., Kov\u00e0\u00e7, P., Wade, W.F.: Effect of saccharide length on the immunogenicity of neoglycoconjugates from synthetic fragments of the O-SP of Vibrio cholerae O1, serotype Ogawa. Carbohydr. Res. 340, 2256\u20132269 (2005). doi:10.1016\/j.carres.2005.07.017","journal-title":"Carbohydr. Res."},{"key":"9160_CR20","doi-asserted-by":"publisher","first-page":"4090","DOI":"10.1128\/IAI.72.7.4090-4101.2004","volume":"72","author":"M.D. Meeks","year":"2004","unstructured":"Meeks, M.D., Saksena, R., Ma, X., Wade, T.K., Taylor, R.K., Kov\u00e0\u00e7, P., et al.: Synthetic fragments of Vibrio cholerae O1 Inaba O-SP bound to a protein carrier are immunogenic in mice but do not induce protective antibodies. Infect. Immun. 72, 4090\u20134101 (2004). doi:10.1128\/IAI.72.7.4090-4101.2004","journal-title":"Infect. Immun."},{"key":"9160_CR21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1128\/jcm.19.2.181-186.1984","volume":"19","author":"L.B. Adams","year":"1984","unstructured":"Adams, L.B., Siebeling, R.J.: Production of Vibrio cholerae O1 and non-O1 typing sera in rabbits immunized with polysaccharide\u2013protein carrier conjugates. J. Clin. Microbiol. 19, 181\u2013186 (1984)","journal-title":"J. Clin. Microbiol."},{"key":"9160_CR22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1099\/00222615-23-1-9","volume":"23","author":"S. Kabir","year":"1987","unstructured":"Kabir, S.: Preparation and immunogenicity of a bivalent cell-surface protein\u2013polysaccharide conjugate of Vibrio cholerae. J. Med. Microbiol. 23, 9\u201318 (1987)","journal-title":"Med. Microbiol."},{"key":"9160_CR23","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1128\/iai.60.8.3201-3208.1992","volume":"60","author":"R.K. Gupta","year":"1992","unstructured":"Gupta, R.K., Szu, S.C., Finkelstein, R.A., Robbins, J.B.: Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin. Infect. Immun. 60, 3201\u20133208 (1992)","journal-title":"Infect. Immun."},{"key":"9160_CR24","first-page":"521","volume":"144","author":"E. Paulovicoca","year":"2006","unstructured":"Paulovicoca, E., Machova, E., Hostacka, A., Bystricky, S.: Immunological properties of complex conjugates based on Vibrio cholerae O1 Ogawa lipopolysaccharide antigen. Clin. Exp. Med. 144, 521\u2013527 (2006)","journal-title":"Clin. Exp. Med."},{"key":"9160_CR25","doi-asserted-by":"publisher","first-page":"S2\/74","DOI":"10.1385\/1597451681","volume":"24S2","author":"O. Cabrera","year":"2006","unstructured":"Cabrera, O., Martinez, M.E., Cuello, M., Soto, C.R., Valmaseda, T., Cedr\u00e9, B., Sierra Gonzalez, G.: Preparation and evaluation of Vibrio cholerae O1 El Tor Ogawa lipopolysaccharide-tetanus toxoid conjugates. Vaccine 24S2, S2\/74\u2013S2\/75 (2006)","journal-title":"Vaccine"},{"key":"9160_CR26","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1128\/IAI.66.7.3095-3099.1998","volume":"66","author":"R.K. Gupta","year":"1998","unstructured":"Gupta, R.K., Taylor, D.N., Bryla, D.A., Robbins, J.B., Szu, S.C.: Phase 1 evaluation of Vibrio cholerae O1 serotype Inaba, polysaccharide\u2013cholera toxin conjugates in adult volonteers. Infect. Immun. 66, 3095\u20133099 (1998)","journal-title":"Infect. Immun."},{"key":"9160_CR27","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/j.1574-695X.2006.00071.x","volume":"47","author":"R. Saksena","year":"2006","unstructured":"Saksena, R., Ma, X., Wade, T.K., Kovac, P., Wade, W.F.: Length of the linker and the interval between immunizations influences the efficacy of Vibrio cholerae O1, Ogawa hexasaccharide neoglycoconjugates. FEMS Immunol. Med. Microbiol. 47, 116\u2013128 (2006). doi:10.1111\/j.1574-695X.2006.00071.x","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"9160_CR28","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/0264-410X(95)00052-3","volume":"13","author":"A. Fattom","year":"1995","unstructured":"Fattom, A., Li, X., Cho, Y.H., Burns, A., Hawwari, A., Shepherd, S.E., et al.: Effect of conjugation methodology, carrier protein, and adjuvants on the immune response to Staphylococcus aureus capsular polysaccharides. Vaccine 13, 1288\u20131293 (1995). doi:10.1016\/0264-410X(95)00052-3","journal-title":"Vaccine"},{"key":"9160_CR29","doi-asserted-by":"publisher","first-page":"5194","DOI":"10.1073\/pnas.96.9.5194","volume":"96","author":"V. Pozsgay","year":"1999","unstructured":"Pozsgay, V., Chu, C., Pannell, L., Wolfe, J., Robbins, J.B., Schneerson, R.: Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1. Proc. Natl. Acad. Sci. U S A 96, 5194\u20135197 (1999). doi:10.1073\/pnas.96.9.5194","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"9160_CR30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bbadis.2003.08.004","volume":"1639","author":"S.N. Chatterjee","year":"2003","unstructured":"Chatterjee, S.N., Chaudhuri, K.: Lipopolysaccharides of Vibrio cholerae I. Physical and chemical characterization. Biochim. Biophys. Acta 1639, 65\u201379 (2003)","journal-title":"Biochim. Biophys. Acta"},{"key":"9160_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0020-2452(96)85762-9","volume":"93","author":"F. Bougoudogo","year":"1995","unstructured":"Bougoudogo, F., V\u00e9ly, F., Nato, F., Boutonnier, A., Gounon, P., Mazie, J.-C., et al.: Protective activities of serum immunoglobulin G on the mucosal surface to Vibrio cholerae O1. Bull. Inst. Pasteur 93, 273\u2013283 (1995). doi:10.1016\/0020-2452(96)85762-9","journal-title":"Bull. Inst. Pasteur"},{"key":"9160_CR32","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/prot.21609","volume":"70","author":"F. Ahmed","year":"2007","unstructured":"Ahmed, F., Andr\u00e9-Leroux, G., Haouz, A., Boutonnier, A., Delepierre, M., Qadri, F., et al.: Crystal structure of a monoclonal antibody directed against an antigenic determinant common to Ogawa and Inaba serotypes of Vibrio cholerae O1. Proteins 70, 284\u2013288 (2007). doi:10.1002\/prot.21609","journal-title":"Proteins"},{"key":"9160_CR33","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1074\/jbc.273.5.2777","volume":"273","author":"J. Wang","year":"1998","unstructured":"Wang, J., Villeneuve, S., Zhang, J., Lei, P., Miller, C.E., Lafaye, P., et al.: On the antigenic determinants of the lipopolysaccharides of Vibrio cholerae O:1, serotypes Ogawa and Inaba. J. Biol. Chem. 273, 2777\u20132783 (1998). doi:10.1074\/jbc.273.5.2777","journal-title":"J. Biol. Chem."},{"key":"9160_CR34","first-page":"83","volume":"5","author":"O. Wesphal","year":"1965","unstructured":"Wesphal, O., Jann, K.: Bacterial lipopolysaccharides, extraction with phenol-water and further applications of the procedure. Methods Carbohydr. Chem. 5, 83\u201391 (1965)","journal-title":"Methods Carbohydr. Chem."},{"key":"9160_CR35","volume-title":"Molecular cloning: a laboratory manual","author":"J. Sambrook","year":"1989","unstructured":"Sambrook, J., Fritsch, E.F., Maniatis, T.: Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, New York (1989)"},{"key":"9160_CR36","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0580-9517(08)70641-X","volume":"5B","author":"D. Herbert","year":"1971","unstructured":"Herbert, D., Phipps, P.J., Strange, R.E.: Chemical analysis of microbial cells. Methods Microbiol. 5B, 209\u2013344 (1971)","journal-title":"Methods Microbiol."},{"key":"9160_CR37","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"O.H. Lowry","year":"1951","unstructured":"Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265\u2013275 (1951)","journal-title":"J. Biol. Chem."},{"key":"9160_CR38","volume-title":"Immunochemistry in Practice","author":"A. Johnstone","year":"1982","unstructured":"Johnstone, A., Thorpe, R.: Immunochemistry in Practice. Blackwell Scientific, Oxford (1982)"},{"key":"9160_CR39","volume-title":"Program ELISA for Windows user\u2019s manual version 1.00","author":"B.D. Plikaytis","year":"1996","unstructured":"Plikaytis, B.D., Holder, P.F., Carlone, G.M.: Program ELISA for Windows user\u2019s manual version 1.00. Centers for Disease Control and Prevention, Atlanta, Ga (1996)"},{"key":"9160_CR40","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.mimet.2003.08.010","volume":"55","author":"A. Boutonnier","year":"2003","unstructured":"Boutonnier, A., Dassy, B., Dum\u00e9nil, R., Gu\u00e9nol\u00e9, A., Ratsitorahina, M., Migliani, R., et al.: A simple and convenient microtiter plate assay for the detection of bactericidal antibodies to Vibrio cholerae O1 and Vibrio cholerae O139. J. Microbiol. Methods 55, 745\u2013753 (2003). doi:10.1016\/j.mimet.2003.08.010","journal-title":"J. Microbiol. Methods"},{"key":"9160_CR41","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1432-1033.1995.152_1.x","volume":"233","author":"E.V. Vinogradov","year":"1995","unstructured":"Vinogradov, E.V., Bock, K., Holst, O., Brade, H.: The structure of the lipid A-core region of the lipopolysaccharides from V. cholerae O1 smooth strain 569B (Inaba) and rough mutant strain 95R (Ogawa). Eur. J. Biochem. 233, 152\u2013158 (1995). doi:10.1111\/j.1432-1033.1995.152_1.x","journal-title":"Eur. J. Biochem."},{"key":"9160_CR42","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0008-6215(00)81047-2","volume":"100","author":"L. Kenne","year":"1982","unstructured":"Kenne, L., Lindberg, B., Unger, P., Gustafsson, B., Holme, T.: Structural studies of the Vibrio cholerae O-antigen. Carbohydr. Res. 100, 341\u2013349 (1982). doi:10.1016\/S0008-6215(00)81047-2","journal-title":"Carbohydr. Res."},{"key":"9160_CR43","first-page":"1901","volume":"135","author":"K. Hisatsune","year":"1989","unstructured":"Hisatsune, K., Hayashi, M., Haishima, Y., Kondo, S.: Relationship between structure and antigenicity of O1 Vibrio cholerae lipopolysaccharides. J. Gen. Microbiol. 135, 1901\u20131907 (1989)","journal-title":"J. Gen. Microbiol."},{"key":"9160_CR44","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1016\/S0021-9258(19)45117-X","volume":"247","author":"W.A. Volk","year":"1972","unstructured":"Volk, W.A., Salomonsky, N.L., Hunt, D.: Xanthomonas sinensis cell wall lipopolysaccharide. J. Biol. Chem. 247, 3881\u20133887 (1972)","journal-title":"J. Biol. Chem."},{"key":"9160_CR45","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1039\/p19910000509","volume":"1","author":"F.-I. Auzanneau","year":"1991","unstructured":"Auzanneau, F.-I., Charon, D., Szab\u00f3, L.: Phosphorylated sugars. Part 27. Synthesis and reactions, in acid medium, of 5-O-substituted methyl 3-deoxy-\u03b1-D-manno-oct-2-ulopyranosidonic acid 4-phosphates. J. Chem. Soc., Perkin Trans. 1, 509\u2013517 (1991). doi:10.1039\/p19910000509","journal-title":"J. Chem. Soc., Perkin Trans."},{"key":"9160_CR46","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1099\/00221287-145-9-2477","volume":"145","author":"S. Villeneuve","year":"1999","unstructured":"Villeneuve, S., Boutonnier, A., Mulard, L.A., Fournier, J.-M.: Immunochemical characterization of an Ogawa-Inaba common antigenic determinant of Vibrio cholerae O1. Microbiology 145, 2477\u20132484 (1999)","journal-title":"Microbiology"},{"key":"9160_CR47","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0065-2318(01)56004-7","volume":"56","author":"V. Pozsgay","year":"2000","unstructured":"Pozsgay, V.: Oligosaccharide\u2013protein conjugates as vaccine candidates against bacteria. Adv. Carbohydr. Chem. Biochem. 56, 153\u2013199 (2000). doi:10.1016\/S0065-2318(01)56004-7","journal-title":"Adv. Carbohydr. Chem. Biochem."},{"key":"9160_CR48","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1039\/b400986j","volume":"2","author":"K. Wright","year":"2004","unstructured":"Wright, K., Guerreiro, C., Laurent, I., Baleux, F., Mulard, L.A.: Preparation of synthetic glycoconjugates as potential vaccines against Shigella flexneri serotype 2a disease. Org. Biomol. Chem. 2, 1518\u20131527 (2004). doi:10.1039\/b400986j","journal-title":"Org. Biomol. Chem."},{"key":"9160_CR49","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0008-6215(01)00318-4","volume":"337","author":"C.J.M. Stroop","year":"2002","unstructured":"Stroop, C.J.M., Xu, Q., Retzlaff, M., Abeygunawardana, C., Bush, C.A.: Structural analysis and chemical depolymerization of the capsular polysaccharide of Streptococcus pneumoniae type 1. Carbohydr. Res. 337, 335\u2013344 (2002). doi:10.1016\/S0008-6215(01)00318-4","journal-title":"Carbohydr. Res."},{"key":"9160_CR50","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0008-6215(00)83665-4","volume":"78","author":"L. Kenne","year":"1980","unstructured":"Kenne, L., Lindberg, B., Petersson, V., Katzenellenbogen, E., Romanowska, E.: Structural studies of the O-specific side chains of the Shigella sonnei phase I lipopolysaccharide. Carbohydr. Res. 78, 119\u2013126 (1980). doi:10.1016\/S0008-6215(00)83665-4","journal-title":"Carbohydr. Res."},{"key":"9160_CR51","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1590\/S0001-37652005000200009","volume":"77","author":"C. Jones","year":"2005","unstructured":"Jones, C.: Vaccines based on the cell surface carbohydrates of pathogenic bacteria. An. Acad. Bras. Cienc. 77, 293\u2013324 (2005). doi:10.1590\/S0001-37652005000200009","journal-title":"An. Acad. Bras. Cienc."},{"key":"9160_CR52","doi-asserted-by":"publisher","first-page":"S2\/76","DOI":"10.1385\/1597451681","volume":"24S2","author":"O. Cabrera","year":"2006","unstructured":"Cabrera, O., Cuello, M., Soto, C.R., Martinez, M.E., del Campo, J.M., P\u00e9rez, O., Infante, J.F., Sierra, G.: New method for obtaining conjugated vaccines. Vaccine 24S2, S2\/76\u2013S2\/78 (2006)","journal-title":"Vaccine"},{"key":"9160_CR53","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1128\/IAI.66.6.2441-2446.1998","volume":"66","author":"C.A. Laferri\u00e8re","year":"1998","unstructured":"Laferri\u00e8re, C.A., Sood, R.H., de Muys, J.M., Michon, F., Jennings, H.J.: Streptococcus pneumoniae type 14 polysaccharide\u2013conjugate vaccines: length stabilization of opsonophagocytic conformational polysaccharide epitopes. Infect. Immun. 66, 2441\u20132446 (1998)","journal-title":"Infect. Immun."},{"key":"9160_CR54","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0022-1759(90)90037-V","volume":"132","author":"P.J. Meikle","year":"1990","unstructured":"Meikle, P.J., Young, N.M., Bundle, D.R.: O-antigen biotin conjugate. Preparation and use in direct competitive enzyme immunoassays. J. Immunol. Methods 132, 255\u2013261 (1990). doi:10.1016\/0022-1759(90)90037-V","journal-title":"J. Immunol. Methods"},{"key":"9160_CR55","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0022-1759(85)90353-9","volume":"82","author":"A. Sutton","year":"1985","unstructured":"Sutton, A., Vann, W.F., Karpas, A.B., Stein, K.E., Schneerson, R.: An avidin-biotin based ELISA for quantitation of antibody to bacterial polysaccharides. J. Immunol. Methods 82, 215\u2013224 (1985). doi:10.1016\/0022-1759(85)90353-9","journal-title":"J. Immunol. Methods"},{"key":"9160_CR56","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0022-1759(90)90014-M","volume":"126","author":"A.F.M. Verheul","year":"1990","unstructured":"Verheul, A.F.M., Versteeg, A.A., Westerdaal, N.A.C., Van Dam, G.J., Jansze, M., Snippe, H.: Measurement of the humoral immune response against Streptococcus pneumoniae type 14-derived antigen by an ELISA and ELISPOT assay based on biotin-avidin technology. J. Immunol. Methods 126, 79\u201387 (1990). doi:10.1016\/0022-1759(90)90014-M","journal-title":"J. Immunol. Methods"},{"key":"9160_CR57","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0022-1759(89)90298-6","volume":"120","author":"J.M. Peeters","year":"1989","unstructured":"Peeters, J.M., Hazendonk, T.G., Beuvery, E.C., Tesser, G.I.: Comparison of four bifunctional reagents for coupling peptides to proteins and the effect of the three moieties on the immunogenicity of the conjugates. J. Immunol. Methods 120, 133\u2013143 (1989). doi:10.1016\/0022-1759(89)90298-6","journal-title":"J. Immunol. Methods"},{"key":"9160_CR58","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/(SICI)1096-9888(199906)34:6<622::AID-JMS814>3.0.CO;2-V","volume":"34","author":"M.M.A. Olsthoorn","year":"1999","unstructured":"Olsthoorn, M.M.A., Haverkamp, J., Thomas-Oates, J.E.: Mass spectrometric analysis of Klebsiella pneumoniae ssp. pneumoniae rough strain R20 (O1\u2212:K20\u2212) lipopolysaccharide preparations: Identification of novel core oligosaccharide components and three 3-deoxy-D-manno-oct-2-ulopyranosic artifacts. J. Mass Spectrom. 34, 622\u2013636 (1999). doi:10.1002\/(SICI)1096-9888(199906)34:6<622::AID-JMS814>3.0.CO;2-V","journal-title":"J. Mass Spectrom."},{"key":"9160_CR59","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0008-6215(90)84182-T","volume":"200","author":"A. Dell","year":"1990","unstructured":"Dell, A., Azadi, P., Tiller, P., Thomas-Oates, J., Jennings, H.J., Beurret, M., et al.: Analysis of oligosaccharide epitopes of meningococcal lipopolysaccharides by fast-atom-bombardment mass spectroscopy. Carbohydr. Res. 200, 59\u201376 (1990). doi:10.1016\/0008-6215(90)84182-T","journal-title":"Carbohydr. Res."},{"key":"9160_CR60","doi-asserted-by":"publisher","first-page":"8433","DOI":"10.1073\/pnas.060022997","volume":"97","author":"S. Villeneuve","year":"2000","unstructured":"Villeneuve, S., Souchon, H., Riottot, M.-M., Mazi\u00e9, J.-C., Lei, P., Glaudemans, C.P.J., Kov\u00e1c, P., Fournier, J.-M., Alzari, P.M.: Crystal structure of an anti-carbohydrate antibody directed against Vibrio cholerae O1 in complex with antigen: molecular basis for serotype specificity. Proc. Natl. Acad. Sci. U S A 97, 8433\u20138438 (2000). doi:10.1073\/pnas.060022997","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"9160_CR61","volume-title":"Bioconjugate Techniques","author":"G.T. Hermanson","year":"1995","unstructured":"Hermanson, G.T.: Bioconjugate Techniques. Academic, San Diego (1995)"},{"key":"9160_CR62","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0008-6215(01)00018-0","volume":"330","author":"A. Chernyak","year":"2001","unstructured":"Chernyak, A., Karavanov, A., Ogawa, Y., Kovac, P.: Conjugating oligosaccharides to proteins by squaric acid diester chemistry: rapid monitoring of the progress of conjugation, and recovery of the unused ligand. Carbohydr. Res. 330, 479\u2013486 (2001). doi:10.1016\/S0008-6215(01)00018-0","journal-title":"Carbohydr. Res."},{"key":"9160_CR63","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/infdis\/121.Supplement.S1","volume":"121","author":"W.H. Mosley","year":"1970","unstructured":"Mosley, W.H., Woodward, W.E., Aziz, K.M.A., Mizanur Rahman, A.S.M., Alauddin Chowdhury, A.K.M., Ahmed, A., et al.: The 1968\u20131969 cholera-vaccine field trial in rural East Pakistan. Effectiveness of monovalent Ogawa and Inaba vaccines and a purified Inaba antigen, with comparative results of serological and animal protection tests. J. Infect. Dis. 121, S1\u2013S9 (1970)","journal-title":"J. Infect. Dis."},{"key":"9160_CR64","first-page":"381","volume":"49","author":"W.H. Mosley","year":"1973","unstructured":"Mosley, W.H., Aziz, K.M.A., Mizanur Rahman, A.S.M., Alauddin Chowdhury, A.K.M., Ahmed, A.: Field trials of monovalent Ogawa and Inaba cholera vaccines in rural Bangladesh\u2014three years of observation. Bull. World Health Organ. 49, 381\u2013387 (1973)","journal-title":"Bull. World Health Organ."},{"key":"9160_CR65","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/978-1-4757-9688-9_14","volume-title":"Cholera","author":"M.L. Levine","year":"1992","unstructured":"Levine, M.L., Pierce, N.F.: Immunity and vaccine development. In: Barua, D., Greenough III, W.B. (eds.) Cholera, pp. 285\u2013327. Plenum, New York (1992)"},{"key":"9160_CR66","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1099\/00222615-16-2-203","volume":"16","author":"H. Brade","year":"1983","unstructured":"Brade, H., Galanos, C.: A new lipopolysaccharide antigen identified in Acinetobacter calcoaceticus: occurrence of widespread natural antibody. J. Med. Microbiol. 16, 203\u2013210 (1983)","journal-title":"J. Med. Microbiol."},{"key":"9160_CR67","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1128\/iai.42.1.250-256.1983","volume":"42","author":"H. Brade","year":"1983","unstructured":"Brade, H., Galanos, C.: Common lipopolysaccharide specificity: new type of antigen residing in the inner core region of S- and R-form lipopolysaccharides from different families of gram-negative bacteria. Infect. Immun. 42, 250\u2013256 (1983)","journal-title":"Infect. Immun."},{"key":"9160_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0022-1759(95)00284-7","volume":"191","author":"C. Boeckler","year":"1996","unstructured":"Boeckler, C., Frisch, B., Muller, S., Schuber, F.: Immunogenicity of new heterobifunctional cross-linking reagents used in the conjugation of synthetic peptides to liposomes. J. Immunol. Methods 191, 1\u201310 (1996). doi:10.1016\/0022-1759(95)00284-7","journal-title":"J. Immunol. Methods"},{"key":"9160_CR69","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.1002\/chem.200400074","volume":"10","author":"T. Buskas","year":"2004","unstructured":"Buskas, T., Li, Y., Boons, G.J.: The immunogenicity of the tumor-associated antigen Lewisy may be suppressed by a bifunctional cross-linker required for coupling to a carrier protein. Chem. Eur. J. 10, 3517\u20133524 (2004). doi:10.1002\/chem.200400074","journal-title":"Chem. Eur. J."},{"key":"9160_CR70","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1126\/science.1095209","volume":"305","author":"V. Verez-Bencomo","year":"2004","unstructured":"Verez-Bencomo, V., Fern\u00e1ndez-Santana, V., Hardy, E., Toledo, M.E., Rodr\u00edguez, M.C., Heynngnezz, L., et al.: A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type b. Science 305, 522\u2013525 (2004). doi:10.1126\/science.1095209","journal-title":"Science"},{"key":"9160_CR71","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1128\/iai.41.2.609-617.1983","volume":"41","author":"E.C. Beuvery","year":"1983","unstructured":"Beuvery, E.C., van Delft, R.W., Miedema, F., Kanhai, V., Nagel, J.: Immunological evaluation of meningococcal group C polysaccharide-tetanus toxoid conjugate in mice. Infect. Immun. 41, 609\u2013617 (1983)","journal-title":"Infect. Immun."},{"key":"9160_CR72","first-page":"521","volume":"40","author":"H. Braley-Mullen","year":"1980","unstructured":"Braley-Mullen, H.: Direct demonstration of specific suppressor T cells in the mice tolerant to type III pneumococcal polysaccharide: two-step requirement for development of detectable suppressor cells. Immunology 40, 521\u2013527 (1980)","journal-title":"Immunology"},{"key":"9160_CR73","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0008-8749(81)90468-8","volume":"64","author":"D. Wilson","year":"1981","unstructured":"Wilson, D., Braley-Mullen, H.: Antigen requirements for priming of type III pneumococcal polysaccharide-specific IgG memory responses: suppression of memory with the T-independent form of antigen. Cell. Immunol. 64, 177\u2013186 (1981). doi:10.1016\/0008-8749(81)90468-8","journal-title":"Cell. Immunol."},{"key":"9160_CR74","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/0264-410X(92)90046-M","volume":"10","author":"C.C.A.M. Peeters","year":"1992","unstructured":"Peeters, C.C.A.M., Tenbergen-Meekes, A.-M.J., Poolman, J.T., Zegers, B.J.M., Rijkers, G.T.: Immunogenicity of a Streptococcus pneumoniae type 4 polysaccharide\u2013protein conjugate vaccine is decreased by admixture of high doses of free saccharide. Vaccine 10, 833\u2013840 (1992). doi:10.1016\/0264-410X(92)90046-M","journal-title":"Vaccine"},{"key":"9160_CR75","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/S0264-410X(98)00129-7","volume":"16","author":"M.E. Rodriguez","year":"1998","unstructured":"Rodriguez, M.E., van den Dobbelsteen, G.P.J.M., Oomen, L.A., de Weers, O., van Buren, L., Beurret, M., et al.: Immunogenicity of Streptococcus pneumoniae type 6B and 14 polysaccharide\u2014tetanus toxoid conjugates and the effect of uncoupled polysaccharide on the antigen-specific immune response. Vaccine 16, 1941\u20131949 (1998). doi:10.1016\/S0264-410X(98)00129-7","journal-title":"Vaccine"},{"key":"9160_CR76","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1016\/S0264-410X(00)00441-2","volume":"19","author":"T. Wuorimaa","year":"2001","unstructured":"Wuorimaa, T., Kaythy, H., Leroy, O., Eskola, J.: Tolerability and immunogenicity of an 11-valent pneumoccocal conjugate vaccine in adults. Vaccine 19, 1863\u20131869 (2001). doi:10.1016\/S0264-410X(00)00441-2","journal-title":"Vaccine"},{"key":"9160_CR77","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1086\/374785","volume":"187","author":"K.K. Kamboj","year":"2003","unstructured":"Kamboj, K.K., Kirchner, H.L., Kimmel, R., Greenspan, N.S., Schreiber, J.R.: Significant variation in serotype-specific immunogenicity of the seven-valent Streptococcus pneumoniae capsular polysaccharide-CRM197 conjugate vaccine occurs despite vigorous T cell help induced by the catrrier protein. J. Infect. Dis. 187, 1629\u20131638 (2003). doi:10.1086\/374785","journal-title":"J. Infect. Dis."}],"container-title":["Glycoconjugate Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10719-008-9160-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10719-008-9160-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10719-008-9160-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10719-008-9160-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T01:35:52Z","timestamp":1744162552000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10719-008-9160-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,23]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["9160"],"URL":"https:\/\/doi.org\/10.1007\/s10719-008-9160-6","relation":{},"ISSN":["0282-0080","1573-4986"],"issn-type":[{"value":"0282-0080","type":"print"},{"value":"1573-4986","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,23]]},"assertion":[{"value":"27 February 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}